"It was a blessing for us," Morefield said. "People who've not had the ongoing medical things we've had don't understand."

Morefield reacted to the Supreme Court decision on Thursday, her birthday, with joy. She called it a great gift that will grant her and her husband peace of mind.

"It's wonderful," she said.

___

Name: Margo Criscuola

Home: Chicago

Age: 66

Occupation: Education consultant

Insurance coverage: Medicare

Criscuola is worried that a controversial board created by President Barack Obama's health overhaul will ration health care and also dictate treatments to doctors. She has family members with a rare genetic condition that she said requires experimental therapies.

"I was listening to the radio this morning and heard the news. I think it's a very sad day for this country, for our medical industry and for our health in this country," Criscuola said.

"If you have a law that requires doctors' treatments to be approved on the basis of their general effectiveness and doctors are not permitted to experiment with other kinds of approaches, that makes it very difficult for special diseases like these to be treated."

The board, called the Independent Payment Advisory Board, is meant to hold down Medicare costs, beginning in 2015. Republicans are targeting the provision for repeal. Criscuola fears the board's influence will go beyond Medicare and permeate the health care system. The White House has said the board is crucial to holding down costs and is barred by the law from rationing care.

The law also encourages a payment model for hospitals, insurers and doctors called "accountable care organizations," which Criscuola believes also will limit doctors' choices in treating patients.

Criscuola has benefited from a provision in the health care law that provides free annual wellness exams to people with Medicare.

"Do I use it? Yeah. Is the benefit I receive from it more than if I had kept the money I paid into Social Security and Medicare payroll taxes and invested it myself? No. It's considerably less," she said. "Will it be around in 15, 20 years? Probably not."

If you liked this article you might like

These Stocks Are Ready to Reverse Course

Don't Get Out of Joint

Zimmer Biomet: Cramer's Top Takeaways

Market Stands at a Make-Or-Break Level: Cramer's 'Mad Money' Recap (Monday 7/17/17)

Analyst Says Rival Bidder Could Emerge for Novadaq After Stryker Deal